Oxidative stress and matrix metalloproteinase-9 in acute ischemic stroke - The biomarker evaluation for antioxidant therapies in stroke (BEAT-stroke) study

被引:299
作者
Kelly, Peter J. [1 ,2 ]
Morrow, Jason D. [6 ]
Ning, MingMing [2 ]
Koroshetz, Walter [2 ]
Lo, Eng H. [3 ]
Terry, Erin [6 ]
Milne, Ginger L. [6 ]
Hubbard, Jane [4 ]
Lee, Hang [5 ]
Stevenson, Elizabeth [2 ]
Lederer, Megan [2 ]
Furie, Karen L. [2 ]
机构
[1] Mater Univ Hosp, Catherine McAuley Res Ctr, Neurovasc Clin Sci Unit, Dublin 7, Ireland
[2] Harvard Univ, Sch Med, Dept Neurol, Stroke Serv, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dept Neurol & Radiol, Neuroprotect Res Lab, Boston, MA USA
[4] Harvard Univ, Sch Med, Mallinckrodt Gen Clin Resource Ctr, Bionutr Serv, Boston, MA USA
[5] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Biostat, Boston, MA USA
[6] Vanderbilt Univ, Sch Med, Dept Med & Pharmacol, Nashville, TN 37212 USA
关键词
cerebrovascular disorders; metalloproteinase; oxidative stress;
D O I
10.1161/STROKEAHA.107.488189
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-Experimental stroke studies indicate that oxidative stress is a major contributing factor to ischemic cerebral injury. Oxidative stress is also implicated in activation of matrix metalloproteinases (MMPs) and blood-brain barrier injury after ischemia-reperfusion. Plasma biomarkers of oxidative stress may have utility as early indicators of efficacy in Phase 2 trials of antioxidant therapies in human stroke. To date, a valid biomarker has been unavailable. We measured F2-isoprostanes (F2IPs), free-radical induced products of neuronal arachadonic acid peroxidation, in acute ischemic stroke. We aimed to determine the change in plasma F2IP levels over time and relationship with plasma MMP-9 in tPA-treated and tPA-untreated stroke patients. Methods-We performed a case-control study of consecutive ischemic stroke patients (25 tPA-treated and 27 tPA-untreated) presenting within 8 hours of stroke onset. Controls were individuals without prior stroke from a primary care clinic network serving the source population from which cases were derived. Infarct volume was determined on acute diffusion-weighted MRI (DWI) performed within 48 hours using a semi-automated computerized segmentation algorithm. Phlebotomy was performed at < 8 hours, 24 hours, 2 to 5 days, and 4 to 6 weeks. F2IPs were measured by gas chromatography/mass spectrometry and MMP-9 by ELISA. Prestroke antioxidant dietary intake was measured by the 24-hour recall method. Results-In 52 cases and 27 controls, early (median 6 hours postonset) F2IPs were elevated in stroke cases compared with controls (medians 0. 041 versus 0.0295pg/mL, P = 0.012). No difference in F2IPSs was present at later time points. Early plasma F2IPs correlated with MMP-9 in all patients (P = 0.01) and the tPA-treated subgroup (P = 0.02). No correlation was found with NIHSS, DWI infarct volume, 90-day Rankin score, or C-reactive protein (P > 0.05 for all). Conclusions-In early human stroke we found evidence of increased oxidative stress and a relationship with MMP-9 expression, supporting findings from experimental studies.
引用
收藏
页码:100 / 104
页数:5
相关论文
共 22 条
[1]
Recommendations for clinical trial evaluation of acute stroke therapies - Stroke Therapy Academic Industry Roundtable II (STAIR-II) [J].
Albers, GW ;
Bogousslavsky, J ;
Bozik, MA ;
Brass, LM ;
Broderick, JP ;
Fisher, M ;
Goldstein, LB ;
Salazar-Grueso, E ;
Akitsuki, S ;
Aranko, K ;
Ashwood, T ;
Atkinson, RP ;
Bell, RD ;
Brott, TG ;
Cady, WJ ;
Caplan, LR ;
Coggins, S ;
Cramer, S ;
Cyrus, P ;
Dayno, J ;
Easton, JD ;
Elliott, PJ ;
Finklestein, SP ;
Furlan, AJ ;
Gamzu, E ;
Glasky, MS ;
Gordon, K ;
Gorelick, PB ;
Greenwood, DT ;
Grotta, JC ;
Gunn, K ;
Hachinski, V ;
Hacke, W ;
Hall, ED ;
Hsu, CY ;
Humphreys, DM ;
Ishikawa, H ;
Jacobs, AJ ;
Kaste, M ;
Koroshetz, WJ ;
Krams, M ;
Lauritano, AA ;
Leclerc, J ;
Lees, KR ;
Lesko, L ;
Levine, SR ;
Levy, DE ;
Li, FH ;
Lyden, PD ;
Masayasu, H .
STROKE, 2001, 32 (07) :1598-1606
[2]
Reduction of tissue plasminogen activator-induced hemorrhage and brain injury by free radical spin trapping after embolic focal cerebral ischemia in rats [J].
Asahi, M ;
Asahi, K ;
Wang, XY ;
Lo, EH .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2000, 20 (03) :452-457
[3]
Plasma levels of antioxidant vitamins, selenium, total sulfhydryl groups and oxidative products in ischemic-stroke patients as compared to matched controls in Taiwan [J].
Chang, CY ;
Lai, YC ;
Cheng, TJ ;
Lau, MT ;
Hu, ML .
FREE RADICAL RESEARCH, 1998, 28 (01) :15-24
[4]
Potential markers of oxidative stress in stroke [J].
Cherubini, A ;
Ruggiero, C ;
Polidori, MC ;
Mecocci, P .
FREE RADICAL BIOLOGY AND MEDICINE, 2005, 39 (07) :841-852
[5]
Oxidative stress in the context of acute cerebrovascular stroke [J].
El Kossi, MMH ;
Zakhary, MM .
STROKE, 2000, 31 (08) :1889-1892
[6]
Matrix metalloproteinase inhibition prevents oxidative stress-associated blood-brain barrier disruption after transient focal cerebral ischemia [J].
Gasche, Y ;
Copin, JC ;
Sugawara, T ;
Fujimura, M ;
Chan, PH .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2001, 21 (12) :1393-1400
[7]
Biomarkers of oxidative stress study II.: Are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? [J].
Kadiiska, MB ;
Gladen, BC ;
Baird, DD ;
Germolec, D ;
Graham, LB ;
Parker, CE ;
Nyska, A ;
Wachsman, JT ;
Ames, BN ;
Basu, S ;
Brot, N ;
FitzGerald, GA ;
Floyd, RA ;
George, M ;
Heinecke, JW ;
Hatch, GE ;
Hensley, K ;
Lawson, JA ;
Marnett, LJ ;
Morrow, JD ;
Murray, DM ;
Plastaras, J ;
Roberts, LJ ;
Rokach, J ;
Shigenaga, MK ;
Sohal, RS ;
Sun, J ;
Tice, RR ;
Van Thiel, DH ;
Wellner, D ;
Walter, PB ;
Tomer, KB ;
Mason, RP ;
Barrett, JC .
FREE RADICAL BIOLOGY AND MEDICINE, 2005, 38 (06) :698-710
[8]
ATTENUATION OF FOCAL CEREBRAL ISCHEMIC-INJURY IN TRANSGENIC MICE OVEREXPRESSING CUZN SUPEROXIDE-DISMUTASE [J].
KINOUCHI, H ;
EPSTEIN, CJ ;
MIZUI, T ;
CARLSON, E ;
CHEN, SF ;
CHAN, PH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (24) :11158-11162
[9]
Oxygen radicals in cerebral ischemia - The 2001 Willis Lecture [J].
Kontos, HA .
STROKE, 2001, 32 (11) :2712-2716
[10]
NXY-059 for acute ischemic stroke [J].
Lees, KR ;
Zivin, JA ;
Ashwood, T ;
Davalos, A ;
Davis, SM ;
Diener, H ;
Grotta, J ;
Lyden, P ;
Shuaib, A ;
Hårdemark, H ;
Wasiewski, WW .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (06) :588-600